Listed by the USPTO as KUBELIK, ANNE R
Tech Center 1600 • Art Units: 1638 1662 1663
This examiner grants 76% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19102957 | KETOL-ACID REDUCTOISOMERASE VARIANT, AND METHOD FOR PRODUCING L-VALINE BY USING SAME | Non-Final OA | CJ CHEILJEDANG CORPORATION |
| 19341179 | MAIZE HYBRID X08V068 | Non-Final OA | PIONEER HI-BRED INTERNATIONAL, INC. |
| 18357624 | INSECT RESISTANT INIR6 TRANSGENIC MAIZE PLANTS LACKING A SELECTABLE MARKER AND JUNCTION | Non-Final OA | INARI AGRICULTURE TECHNOLOGY, INC. |
| 18708993 | HIGH FLAVONOID CORN AND USES THEREOF | Final Rejection | THE PENN STATE RESEARCH FOUNDATION |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy75.8% of resolved applications examined by Anne R Kubelik were allowed (1,352 resolved cases), compared with 48.8% across Art Unit 1638 over the last five years.
This examiner's interview lift is -1.1 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Anne R Kubelik took 1,002 days on average from filing to allowance.
Anne R Kubelik examines applications in Art Unit 1638 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
